Press release
SNP Genotyping Market to Reach USD 39.2 Bn by 2034
SNP Genotyping Market
Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation, occurring once in every 300 nucleotides on average. SNP genotyping has become a cornerstone of genomics, enabling researchers and clinicians to identify genetic predispositions, understand disease mechanisms, develop targeted therapies, and improve crop and livestock breeding.
The integration of high-throughput technologies, falling sequencing costs, and rising demand for personalized medicine are fueling market growth. By 2024, the SNP genotyping market size is estimated at USD 11.3 billion and is projected to reach USD 39.2 billion by 2034, expanding at a CAGR of 13.5% during 2025-2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72390
Market Overview
Key highlights of the global SNP genotyping market:
• Market Size 2024: USD 11.3 billion
• Forecast 2034: USD 39.2 billion
• CAGR (2025-2034): ~13.5%
• Key Drivers: Growing adoption of precision medicine, rising prevalence of genetic disorders, advancements in sequencing and PCR technologies, and applications in agriculture and animal genetics.
• Challenges: High data interpretation costs, ethical concerns in genetic testing, and limited adoption in resource-constrained settings.
• Leading Players: Illumina, Thermo Fisher Scientific, Agilent Technologies, Qiagen, Bio-Rad Laboratories, Fluidigm, Pacific Biosciences, Affymetrix (part of Thermo Fisher), Danaher (Cepheid), and Eurofins Scientific.
The market is highly competitive and innovation-driven, with companies expanding applications in healthcare, pharmaceuticals, agriculture, and forensics.
Segmentation Analysis
By Technology
• TaqMan SNP Genotyping Assays
• SNP GeneChip Arrays
• Real-Time PCR
• Next-Generation Sequencing (NGS)-Based Genotyping
• MassARRAY System
• Others (Microarrays, Hybridization-Based Assays)
By Application
• Diagnostics & Personalized Medicine
• Pharmacogenomics & Drug Discovery
• Agricultural Biotechnology (Crop & Livestock Improvement)
• Forensics & Paternity Testing
• Research Applications
By Product & Service
• Instruments
• Consumables (Reagents, Kits, Arrays)
• Software & Bioinformatics Tools
• Genotyping Services
By End User
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Agricultural & Animal Research Centers
Summary:
Healthcare dominates the market due to rising use of SNP genotyping in cancer, cardiovascular, and neurological disorders, while agriculture and livestock genetics are emerging as high-growth segments, ensuring food security and sustainability.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72390/single-nucleotide-polymorphism-snp-genotyping-market
Regional Analysis
North America
• Largest market, driven by strong funding for genomics, high adoption of precision medicine, and the presence of key market players.
• The U.S. leads in clinical diagnostics and large-scale population genomics projects.
Europe
• Strong adoption in pharmacogenomics and agricultural biotechnology.
• Germany, the UK, and France are major markets, supported by research collaborations and EU-backed genomic initiatives.
Asia-Pacific
• Expected to record the fastest CAGR through 2034, driven by rising demand for genetic testing, growing investments in agriculture genomics, and government support in countries like China, India, and Japan.
Middle East & Africa
• Gradual adoption with growth supported by initiatives in precision medicine in Gulf countries like UAE and Saudi Arabia.
• Limited infrastructure remains a challenge in several African nations.
Latin America
• Brazil and Mexico lead regional adoption, supported by genetic research programs and expansion in agricultural genomics.
Summary:
North America and Europe dominate today, but Asia-Pacific is emerging as the fastest-growing region, thanks to its strong investments in both healthcare and agricultural genomics.
Market Dynamics
Key Growth Drivers
• Increasing role of SNP biomarkers in disease risk prediction.
• Growing use of SNP genotyping in pharmacogenomics and drug development.
• Expanding applications in crop and livestock genetics for higher yields and disease resistance.
• Falling costs of sequencing and genotyping technologies.
• Government-backed population genomics projects.
Key Challenges
• High costs of data storage, analysis, and interpretation.
• Ethical and privacy concerns regarding genetic testing.
• Limited skilled workforce in bioinformatics.
• Uneven access to advanced genomic technologies in developing economies.
Latest Trends
• Integration of AI and machine learning for faster SNP analysis.
• Growth of direct-to-consumer (DTC) genetic testing services.
• Rising use of SNP panels in liquid biopsy and oncology diagnostics.
• Development of portable sequencing devices for field applications.
• Strategic partnerships between pharma, biotech, and agriculture companies.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72390
Competitor Analysis
Major Players
• Illumina - Leading provider of sequencing and genotyping platforms.
• Thermo Fisher Scientific - Offers a wide range of PCR and SNP assay technologies.
• Agilent Technologies - Strong in genomic tools and microarrays.
• Qiagen - Provides sample prep and genotyping assays.
• Bio-Rad Laboratories - Offers PCR-based SNP genotyping solutions.
• Fluidigm - Specializes in microfluidics-based genotyping.
• Pacific Biosciences (PacBio) - Known for long-read sequencing applications.
• Affymetrix (Thermo Fisher) - Pioneer in SNP microarrays.
• Danaher (Cepheid) - Provides diagnostic systems integrating SNP analysis.
• Eurofins Scientific - Expands genotyping services across multiple applications.
Summary:
Illumina and Thermo Fisher dominate the market, while companies like PacBio and Fluidigm are driving innovations in niche applications. Strategic collaborations and service expansions are key competitive strategies.
Conclusion
The single nucleotide polymorphism (SNP) genotyping market is on a strong growth trajectory, expanding from USD 11.3 billion in 2024 to USD 39.2 billion by 2034, at a CAGR of 13.5%.
Key Takeaways:
• Healthcare and diagnostics dominate current applications, particularly in oncology and genetic diseases.
• Pharmacogenomics and agriculture offer new high-growth opportunities.
• North America and Europe lead today, but Asia-Pacific is the fastest-growing region.
• AI integration, falling sequencing costs, and population genomics projects are reshaping the market.
This report is also available in the following languages : Japanese (一塩基多型(SNP)遺伝子型判定市場), Korean (단일 뉴클레오티드 다형성(SNP) 유전자형 분석 시장), Chinese (单核苷酸多态性(SNP)基因分型市场), French (Marché du génotypage des polymorphismes nucléotidiques simples (SNP)), German (Markt für Einzelnukleotid-Polymorphismus (SNP)-Genotypisierung), and Italian (Mercato della genotipizzazione del polimorfismo a singolo nucleotide (SNP)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72390
Our More Reports:
North America Robotic Surgery Market
https://exactitudeconsultancy.com/reports/72334/north-america-robotic-surgery-market
North America ERCP and PTC Devices Market
https://exactitudeconsultancy.com/reports/72322/north-america-ercp-and-ptc-devices-market
North America Gastric Bands and Balloons Market
https://exactitudeconsultancy.com/reports/72320/north-america-gastric-bands-and-balloons-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SNP Genotyping Market to Reach USD 39.2 Bn by 2034 here
News-ID: 4198221 • Views: …
More Releases from Exactitude Consultancy
EU5 Hernia Repair Devices Market to Reach €1.9 Billion by 2034
Hernia remains one of the most common surgical conditions worldwide, with millions of cases reported annually. Characterized by the protrusion of an organ or tissue through an abnormal opening, hernias often require surgical intervention for effective treatment. Hernia repair devices-including meshes, fixation instruments, and prosthetics-play a pivotal role in improving surgical efficiency, reducing recurrence rates, and ensuring faster patient recovery.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72349
The EU5…
Meditation Market Poised for Strong Growth, Expected to Reach USD 17.4 Billion b …
Introduction
Meditation, once rooted deeply in spiritual and cultural traditions, has evolved into a mainstream wellness practice globally. Increasing stress levels, mental health challenges, and lifestyle-related disorders have significantly boosted demand for meditation solutions ranging from in-person classes to mobile apps and AI-driven platforms.
The market is benefitting from corporate wellness initiatives, the rise of digital meditation apps, and scientific validation of meditation's impact on stress reduction, focus, and overall health. By…
Asia-Pacific Surgical Energy Devices Market Forecasted to Reach USD 5.8 Billion …
Surgery is evolving rapidly, with advanced medical technologies reshaping how procedures are performed and outcomes are achieved. Among these innovations, surgical energy devices-instruments that use energy sources like ultrasound, radiofrequency, and lasers to cut, coagulate, ablate, or dissect tissue-play a vital role in modern surgical practices. They not only improve surgical precision but also reduce blood loss, shorten recovery times, and enhance patient safety.
Download Full PDF Sample Copy of Market…
Asia-Pacific Surgical Stapling Devices Market Forecasted to Reach USD 2.7 Billio …
The surgical landscape is undergoing a profound transformation, with healthcare providers increasingly seeking tools that enhance precision, reduce operative time, and improve patient recovery outcomes. Among the most significant innovations are surgical stapling devices, which have largely replaced traditional suturing in many procedures. These devices are used to close wounds, connect or remove tissues, and perform complex surgical tasks across multiple specialties.
Download Full PDF Sample Copy of Market Report @…
More Releases for SNP
Booming SNP Genotyping Market: Rapid Growth, Major Players, and Emerging Trends
"The global single nucleotide polymorphism genotyping market showcases a robust growth rate powered by advancements and increasing demand in the field.
What Is The Projected Market Size Of The Global Single Nucleotide Polymorphism (SNP) Genotyping Market And Its Growth Rate?
The SNP genotyping market size has experienced rapid growth in recent years and is projected to continue this trend. Differences in data are as follows:
• Growth from $10.3 billion in 2024 to…
SNP Chips: Revolutionizing Genetic Research and Breeding in the Modern Era
In the rapidly evolving landscape of genomics, Single Nucleotide Polymorphism (SNP) chips have emerged as powerful tools transforming genetic research and breeding practices across diverse sectors, from agriculture to livestock and even human health. As technological advancements continue to accelerate, these chips are becoming increasingly sophisticated, allowing scientists to unravel the complexities of the genome with unprecedented precision and efficiency.
The Rise of SNP Chips
SNP chips, also known as genotyping arrays,…
SNP genotyping Market 2023 Driving Factors Forecast Research 2029
SNP genotyping market is anticipated to grow at a significant CAGR of 20.5% during the forecast period. The market is mainly driven by increasing R&D projects in genotyping domain, and rising funding in the biotechnology industry. The biopharmaceutical companies are investing heavily in the R&D projects, attributed to advances and discoveries. From genomics to personalized medicines, all the recent advancement has created significant scope in developing unique treatment options for…
SNP genotyping Market Outlook 2029: Presents Market Insights & Depth Analysis
The global SNP Genotyping market is anticipated to grow at a CAGR of 20.5% during the forecast period (2023-2030). Genotyping detects tiny differences in genetic sequence within populations such as single-nucleotide polymorphisms (SNPs). SNP technology is used to study the genetic elements of complex diseases. SNPs are markers that are utilized in different human ailments and are employed in pharmacogenomics to provide medicine according to the need. Thus, the rising…
Explore Single Nucleotide Polymorphism (SNP) Genotyping Market Demand 2020 - 202 …
According to a new report published by Allied Market Research, titled, "World Single Nucleotide Polymorphism (SNP) Genotyping Market - Opportunities and Forecasts, 2019-2026"
The global market size of Single Nucleotide Polymorphism (SNP) Genotyping is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan
Key…
Polyvinyl Alcohol (PVA) Market Forecast 2018 - 2028 | KURARAY, Polysciences, Pol …
Polyvinyl Alcohol (PVA) Market: Overview
Polyvinyl alcohol (PVA), is a synthetic polymer which is soluble in water. It is an important compound utilized in making process in several end-use sectors. The major end-use sectors are construction, food packaging, electronics, printing, coatings, textile, paper, and cosmetics. PVA compound is majorly boosted by the rising demand from the food packaging sector, as it providea more solubility in water is a material with better…
